🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs
5,427

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Page 82 of 114

  1. SB11 (Proposed ranibizumab biosimilar)

    Samsung Bioepis NL B.V.

    Age-Related Macular Degeneration

    phase 3 small molecule completed

    1 trial

  2. SBRT

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 3 other active

    3 trials

  3. SC treatment with IGSC, 10% with rHuPH20 followed by SC/IGSC, 10% only (safety)

    Takeda

    Primary Immunodeficiency Diseases (PID)

    phase 3 mab completed

    1 trial

  4. SCENESSE 16 mg implant

    Clinuvel Europe Limited

    Vitiligo

    phase 3 small molecule active

    1 trial

  5. SD-809

    Teva Pharma GmbH

    Chorea Associated With Huntington Disease

    phase 3 small molecule completed

    1 trial

  6. SD-809

    Teva Pharma GmbH

    Tardive Dyskinesia

    phase 3 small molecule completed

    3 trials

  7. SD-809

    Teva Pharma GmbH

    Chorea

    phase 3 small molecule completed

    1 trial

  8. SDF solution

    The University of Hong Kong

    Dental Caries

    phase 3 other completed

    1 trial

  9. SECUKINUMAB

    Novartis Pharmaceuticals

    Polymyalgia Rheumatica

    phase 3 small molecule active

    1 trial

  10. SEG101

    Novartis Pharmaceuticals

    Sickle cell disease

    phase 3 small molecule active

    1 trial

  11. SELINEXOR, Selinexor placebo for 20 mg tablets is formulated for oral administration. selinexor placebo tablets are film coated bi-convex round tablets

    Karyopharm Therapeutics Inc

    endometrial cancer

    phase 3 small molecule active

    1 trial

  12. SELPERCATINIB, CARBOPLATIN , SELPERCATINIB, PEMBROLIZUMAB, CISPLATIN , PEMETREXED

    Eli Lilly Co.

    Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  13. SELUMETINIB, SELUMETINIB, Placebo to match Selumetinib capsules, 10 and 25 mg.

    AstraZeneca AB

    Neurofibromatosis Type 1 (NF1) with Symptomatic, Inoperable Plexiform Neurofibromas (PN).

    phase 3 small molecule active

    1 trial

  14. SER-109

    Seres Therapeutics

    Clostridium Difficile Infection

    phase 3 mab completed

    1 trial

  15. SER-109

    Seres Therapeutics

    Clostridioides Difficile Infection

    phase 3 mab completed

    1 trial

  16. SERTRALINE , LITHIUM , ESCITALOPRAM , QUETIAPINE, VENLAFAXINE , VALPROIC ACID , BUPROPION

    Disc Medicine

    Bipolar depression

    phase 3 small molecule active

    1 trial

  17. SEVOFLURANE, DEXMEDETOMIDINE HYDROCHLORIDE

    The George Institute

    Children under the age of 2 years having surgery lasting at least 2 hours

    phase 3 small molecule active

    1 trial

  18. SGM-101

    BRIGHT MINDS BIOSCIENCES INC.

    Rectal Cancer

    phase 3 small molecule active

    1 trial

  19. SGT-003

    Solid Biosciences

    Duchenne Muscular Dystrophy

    phase 3 gene therapy active

    2 trials

  20. SHP465

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    phase 3 small molecule completed

    4 trials

  21. SHP465 12.5mg capsules (one capsule daily)

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    phase 3 small molecule completed

    1 trial

  22. SHP615

    Shire

    Nervous System Diseases

    phase 3 small molecule completed

    1 trial

  23. SHP615

    Takeda

    Nervous System Diseases

    phase 3 small molecule completed

    2 trials

  24. SHP640

    Takeda

    Bacterial Conjunctivitis

    phase 3 small molecule completed

    1 trial

  25. SHP640

    Takeda

    Adenoviral Conjunctivitis

    phase 3 small molecule terminated

    2 trials

  26. SHR-1210

    Jian Li

    Locally Advanced or Metastatic and Unresectable HCC

    phase 3 small molecule completed

    1 trial

  27. SHR-A2009 ; Aumolertinib

    Suzhou Ribo Life Science Co.

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  28. SKY0402

    Pacira Ireland Limited

    Hemorrhoid

    phase 3 small molecule completed

    1 trial

  29. SKY0402

    Pacira Ireland Limited

    Bunion

    phase 3 small molecule completed

    1 trial

  30. SKY0402

    Pacira Ireland Limited

    Pain

    phase 3 small molecule terminated

    1 trial

  31. SMC021 Oral Calcitonin

    Nordic Bioscience A/S

    Osteoarthritis

    phase 3 small molecule completed

    1 trial

  32. SMC021 Oral calcitonin

    Nordic Bioscience A/S

    Osteoporosis

    phase 3 small molecule completed

    1 trial

  33. SOC plus 15mg/kg EB05 IV

    Edesa Biotech

    COVID-19

    phase 3 mab on hold

    1 trial

  34. SODIO CLORURO 0,9% BAXTER Soluzione per infusione, KETAMINA MOLTENI 50 mg/ml soluzione iniettabile

    Talion

    Major Depressive Disorder (MDD)

    phase 3 small molecule active

    1 trial

  35. SODIO CLORURO 0,9% BAXTER Soluzione per infusione, KETAMINA MOLTENI 50 mg/ml soluzione iniettabile

    Talion

    Major Depressive Disorder (MDD)

    phase 3 small molecule active

    1 trial

  36. SODIUM CHLORIDE , CAEL-101

    Alexion Europe SAS

    stage IIIa cardiac AL amyloidosis

    phase 3 small molecule active

    1 trial

  37. SODIUM CHLORIDE , CAEL-101

    Alexion Europe SAS

    Stage IIIb cardiac AL amyloidosis

    phase 3 small molecule active

    1 trial

  38. SODIUM CHLORIDE , DYNE-101

    Dyne Therapeutics

    Myotonic Dystrophy Type 1

    phase 3 small molecule active

    1 trial

  39. SODIUM CHLORIDE , RITUXIMAB, MYCOPHENOLIC ACID

    Tour Hekla

    Intersitial lung disease related to systemic sclerosis

    phase 3 small molecule active

    1 trial

  40. SODIUM CHLORIDE, Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    Pari Pharma GmbH

    HPV vaccine

    phase 3 small molecule active

    1 trial

  41. SODIUM CHLORIDE, HYDROCORTISONE UPJOHN 100 mg, préparation injectable, Placebo of hydrocortisone 100 mg, Reverpleg 40 U.I./2 ml solution à diluer pour perfusion

    Pari Pharma GmbH

    Adult cardiac arrest patients with sustained ROSC and hemodynamic failure due to post-resuscitation syndrome

    phase 3 small molecule active

    1 trial

  42. SODIUM CHLORIDE, Kineret 100 mg/0.67 ml solution for injection in pre-filled syringe.

    Pari Pharma GmbH

    PEDIATRIC ACUTE MYOCARDITIS

    phase 3 small molecule active

    1 trial

  43. SODIUM CHLORIDE, LEVETIRACETAM VIATRIS 100 mg/ml, solution à diluer pour perfusion

    Pari Pharma GmbH

    Adult ICU patients with septic shock

    phase 3 small molecule active

    1 trial

  44. SODIUM CHLORIDE, MYCOPHENOLATE MOFETIL, GLUCOSE, Oleclumab, MYCOPHENOLATE MOFETIL, IMFINZI 50 mg/mL concentrate for solution for infusion., Monalizumab, IMFINZI 50 mg/mL concentrate for solution for infusion., INFLIXIMAB

    AstraZeneca AB

    Patients With Locally Advanced (Stage III), Unresectable Non-small Cell Lung Cancer (NSCLC)

    phase 3 small molecule active

    1 trial

  45. SODIUM CHLORIDE, ROPIVACAINE

    Pari Pharma GmbH

    Cancer surgery

    phase 3 small molecule active

    1 trial

  46. SODIUM CHLORIDE, Truxima 500 mg concentrate for solution for infusion

    Pari Pharma GmbH

    Patient with stabilized SSc-ILD (as defined by a decline of FVC ≤ 5%) following RTX induction treatment

    phase 3 small molecule active

    1 trial

  47. SODIUM CHLORIDE, VRDN-001 (Insulin-like growth factor-1 receptor [IGF-1R] inhibitor)

    Viridian Pharma Ltd

    Thyroid eye disease

    phase 3 small molecule active

    1 trial

  48. SODIUM CHLORIDE, VRDN-001 (Insulin-like growth factor-1 receptor [IGF-1R] inhibitor), VRDN-001 (Insulin-like growth factor-1 receptor [IGF-1R] inhibitor)

    Viridian Pharma Ltd

    Thyroid eye disease (TED)

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.